FG
KIDS icon

Fairman Group’s OrthoPediatrics KIDS Stock Holding History

Fairman Group’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38
Closed -$1.03K – 374
2024
Q3 		$1.03K Hold
38
– – ﹤0.01% 335
2024
Q2 		$1.09K Hold
38
– – ﹤0.01% 323
2024
Q1 		$1.11K Hold
38
– – ﹤0.01% 320
2023
Q4 		$1.24K Buy
+38
New +$1.1K ﹤0.01% 305

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fairman Group's KIDS Position: Q4 2024 in Review

Fairman Group sold out of OrthoPediatrics (KIDS) in Q4 2024, closing a stake of 38 shares — an estimated $1.03K sold.

Fairman Group first reported a position in KIDS in Q4 2023 and held it in 4 quarters. The position peaked at $1.24K in Q4 2023. 108 funds tracked by Wall St. Rank hold KIDS as of Q4 2024.

  • Fairman Group reported no remaining OrthoPediatrics position as of Q4 2024 after selling out during the quarter.
  • Fairman Group sold 38 OrthoPediatrics shares in Q4 2024, an estimated $1.03K.
  • Fairman Group first reported a position in OrthoPediatrics in Q4 2023 and held it in 4 quarters.
  • Fairman Group's OrthoPediatrics position peaked at $1.24K in Q4 2023.
  • 108 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2024.

Based on Fairman Group's 13F filing for Q4 2024, filed 29 Jan 2025.